Terrosu P, Franceschino V, Contini G M, Dore L, Ibba G V
G Ital Cardiol. 1984 Jan;14(1):63-6.
The Authors describe a patient with hypertrophic cardiomyopathy (HCM), severe left ventricular outflow tract obstruction and lack of response to beta-blockers or verapamil. Intravenous infusion of disopyramide resulted in a virtual disappearance of the LV pressure gradient, reduction of the systolic anterior motion of the mitral valve and slowing of the LV isovolumetric relaxation. One month after maintenance therapy with oral disopyramide a decrease of the anginal episodes and an improvement of the exercise tolerance were noted. Thus disopyramide, probably because of its negative inotropic action, is useful in the management of patients with HCM when LV outflow obstruction is the main cause of the clinical-hemodynamic findings.
作者描述了一名患有肥厚型心肌病(HCM)、严重左心室流出道梗阻且对β受体阻滞剂或维拉帕米无反应的患者。静脉输注丙吡胺导致左心室压力梯度几乎消失、二尖瓣收缩期前向运动减少以及左心室等容舒张减慢。口服丙吡胺维持治疗1个月后,心绞痛发作次数减少,运动耐量改善。因此,丙吡胺可能因其负性肌力作用,在左心室流出道梗阻是临床血流动力学表现的主要原因时,对肥厚型心肌病患者的管理有用。